- Oops!Something went wrong.Please try again later.
- Oops!Something went wrong.Please try again later.
Koninklijke Philips N.V. PHG reported fourth-quarter 2020 adjusted earnings of €0.83 per share, up 13.3% year over year.
Sales increased 0.7% on a year-over-year basis to €6 billion. Comparable sales (includes adjustments for consolidation charges & currency effects) increased 7% year over year, primarily due to double-digit comparable sales growth in the Connected Care business, mid-single-digit growth in the Personal Health business and low-single-digit growth in the Diagnosis & Treatment businesses.
The company’s comparable order intake grew 7% year over year.
Sales increased 7% on a comparable basis in growth geographies, driven by double-digit growth in Central & Eastern Europe and Russia & Central Asia and high single-digit growth in Middle East & Turkey, partially offset by a decline in China. Comparable order intake declined mid-single digit.
Sales in mature geographies were up 6% year over year on a comparable basis. Western Europe witnessed 14% year-over-year growth and North America sales grew 1%.
Markedly, Philips’ shares have returned 14.1% to date against the Zacks Electronics- Miscellaneous Products industry’s rally of 22.8%.
Koninklijke Philips N.V. Price, Consensus and EPS Surprise
Koninklijke Philips N.V. price-consensus-eps-surprise-chart | Koninklijke Philips N.V. Quote
Diagnosis & Treatment revenues declined 5% from the year-ago quarter to €2.46 billion. Comparable sales inched up 1% year over year.
Diagnostic Imaging grew high-single digit. However, both Image-Guided Therapy and Ultrasound revenues declined mid-single digit due to COVID-19-led postponement of installations and elective procedures.
Comparable sales in growth geographies showed mid-single-digit growth, driven by double-digit growth in China and Central & Eastern Europe.
Mature geographies declined at a low-single-digit rate, reflecting mid-single-digit decline in North America. Western Europe witnessed low-single-digit growth.
Connected Care business revenues grew 17% to €1.58 billion. Comparable sales increased 24%, primarily driven by COVID-19-generated demand with double-digit growth in both Sleep & Respiratory Care and Monitoring & Analytics.
Mature geographies grew in double digits, primarily on double-digit growth in Western Europe and North America.
Growth geographies showed double-digit growth, driven by double-digit growth in Central & Eastern Europe, Russia & Central Asia, and Latin America, as well as high-single-digit growth in China.
Personal Health sales decreased 1% year over year to €1.82 billion. Comparable sales were up 5% with double-digit growth in Domestic Appliances, mid-single-digitgrowth in Personal Care and alow-single-digit growth in Oral Healthcare.
Growth geographies increased low-single digit, primarily due to double-digit growth in Middle East & Turkey, India, Latin America and Russia & Central Asia, partially offset by China. Mature geographies posted a high-single-digit sales growthdriven by double-digit growth in Western Europe.
Other segment sales dropped 19.8% to €138 million, primarily due to lower royalty income.
Gross margin expanded 230 basis points (bps) on a year-over-year basis to 47.8% in the reported quarter.
General & administrative expenses as percentage of sales increased 50 bps on a year-over-year basis to 2.9%. However, selling expenses decreased 50 bps to 21.2%. Research & development expenses also decreased 90 bps to 8.2%.
In the reported quarter, procurement cost savings totaled €67 million. Savings from overhead and other productivity programs were €56 million.
Philips’ adjusted earnings before interest, taxes and amortization (“EBITA”) — the company’s preferred measure of operational performance — were €1.14 billion, up 6.8% from the year-ago quarter.
Adjusted EBITA margin expanded 110 bps on a year-over-year basis to 19%. COVID-19 negatively impacted adjusted EBITA by roughly 40 bps.
Diagnosis & Treatment EBITA margins contracted 230 bps on a year-over-year basis to 14%. Moreover, Personal Health adjusted EBITA margins contracted 10 bps.
Connected Care adjusted EBITA margin improved to 27.2% compared with 19.4% in the year-ago quarter.
Balance Sheet & Other Details
As of Dec 31, 2020, Philips’ cash and cash equivalents were €3.27 billion and total debt was €6.93 billion. This compares with cash and cash equivalents of €2.49 billion and total debt of €7.23 billion as of Sep 30, 2020.
Meanwhile, net cash flow generated from operating activities came in at €2.78 billion, up 36.7% year over year. Free cash flow was €1.85 billion, compared with €1.05 billion in the year-ago quarter.
For 2021, Philips plans to deliver low-single-digit comparable sales growth, driven by solid growth in Diagnosis & Treatment and Personal Health, partly offset by lower Connected Care sales. Adjusted EBITA margin is expected to improve 60-80 bps.
For 2021-2025, Philips targets average annual comparable sales growth in the 5-6% range.
Adjusted EBITA margin is expected to expand 60-80 bps on average annually between 2021 and 2025 timeframe.
Moreover, free cash flow is expected to be above €2 billion by 2025.
Zacks Rank and Other Stocks to Consider
Phillips currently sports a Zacks Rank #2 (Buy).
Littelfuse LFUS, Kulicke&Soffa KLIC and Knowles KN are better-ranked stocks worth considering from the broader computer and technology sector. All the three stocks flaunt a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
Moreover, while Littelfuse is set to report their quarterly results on Feb 3, both Kulicke&Soffa and Knowles are scheduled to report the same on Feb 4.
Just Released: Zacks’ 7 Best Stocks for Today
Experts extracted 7 stocks from the list of 220 Zacks Rank #1 Strong Buys that has beaten the market more than 2X over with a stunning average gain of +24.4% per year.
These 7 were selected because of their superior potential for immediate breakout.
See these time-sensitive tickers now >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Koninklijke Philips N.V. (PHG) : Free Stock Analysis Report
Littelfuse, Inc. (LFUS) : Free Stock Analysis Report
Knowles Corporation (KN) : Free Stock Analysis Report
Kulicke and Soffa Industries, Inc. (KLIC) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research